PIK3CA and metastatic neoplasm: Furthermore, Mosele and colleagues recently reported that patients with PIK3CA-mutated metastatic tumors presented with a poor prognosis and resistance to chemotherapy in hormone receptor-positive, HER2-negative metastatic breast cancer34.